Clinical Trial: A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938815) titled 'A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color' on April 02.

Brief Summary: This is a single-center, prospective, non-blinded, non-randomized 12 week clinical study to evaluate the efficacy of a SkinCeuticals comprehensive skin care regimen in the reduction of post inflammatory hyperpigmentation (PIH) in skin of color patients. The comprehensive regimen features the Pigment Balancing Peel which combines glycolic acid, lactic acid, kojic acid, vitamin C, and emblica into a treatment that may improve skin discoloration. Participants will supplement the Pigment Balancing Peel with ...